Vertigo drug therapy and vertigo as a side effect of drugs. Vertigo from a pharmacological point of view;Die schwindeltablette - Nur ein tablettenschwidel?: Schwindel aus pharmakologischer sicht

Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung

Volumn 94, Issue 6, 2000, Pages 501-507

  Fleck, Christian ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Meniere's disease; Seasickness; Side effects of drugs; Vertigo; Vertigo drug therapy; Vestibular lesions; Vomiting

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; BETAHISTINE; NEUROLEPTIC AGENT; PENTOXIFYLLINE; PREDNISOLONE; SCOPOLAMINE; HYPNOTIC SEDATIVE AGENT; VASODILATOR AGENT;

ANTIBIOTIC THERAPY; HOMEOPATHY; INNER EAR DISEASE; MENIERE DISEASE; REVIEW; VERTIGO; VESTIBULAR DISORDER; VOMITING; CHEMICALLY INDUCED DISORDER; HUMAN;

HUMANS; HYPNOTICS AND SEDATIVES; PENTOXIFYLLINE; SCOPOLAMINE; VASODILATOR AGENTS; VERTIGO; VOMITING;

EID: 0033623284     PISSN: 14317621     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Ballantyne J, Ajodhia J (1984) Iatrogenic dizziness. In: Dix MR, Hood DJ (eds) Vertigo. Chichester: John Wiley and Sons, S. 217-247
2. Brandt T (1991) Vertigo: Its multisensory syndromes. Berlin u. a.: Springer
3. Cullen JR, Hall SJ, Allen RH (1989) Effect of betahistine dihydrochloride compared with cinnarizine on induced vestibular nystagmus. Clin Otolaryngol 14: 485-487
4. Fujino A, Tokumasu K, Okamoto M, et al (1996) Vestibular training for acute unilateral vestibular disturbances: its efficacy in comparison with antivertigo drug. Acta Otolaryngol Suppl Stockh 524: 21-26
5. Glasscock III ME, Cueva RA, Thedinger BA (1990) Handbook of vertigo. New York: Raven Press
6. Hirsch BE, Kamerer DB (1997) Intratympanic gentamicin therapy for Menière's disease. Am J Otol 18: 44-51
7. Jahnke K (1994) Stadiengerechte Therapie der Menièreschen Krankheit. Dt Ärztebl 91: A-428-434
8. Kawabata A, Sasa M, Kishimoto T, et al (1991) Effects of anti-vertigo drugs on medial vestibular nucleus neurons activated by horizontal rotation. Jpn J Pharmacol 55: 101-106
9. Kingma H, Bonink M, Meulenbroeks A, et al (1997) Dose-dependent effect of betahistine on the vestibulo-ocular reflex: a double-blind, placebo controlled study in patients with paroxysmal vertigo. Acta Otolaryngol Stockh 117: 641-646
10. Luetje CM, Wooten J (1996) Clinical manifestations of transdermal scopolamine addiction. Ear Nose Throat J 75: 210-214
11. Navarro-Badenes J, Martinez-Mir I, Palop V, et al (1992) Weight gain associated with cinnarizine. Ann Pharmacother 26: 928-930
12. Oosterveld WJ (1984) Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study. J Laryngol Otol 98: 37-41
13. Pyykko I, Magnusson M, Schalen L, et al (1988) Pharmacological treatment of vertigo. Acta Otolaryngol Suppl Stockh 455: 77-81
14. Rascol O, Hain TC, Brefel C, et al (1995) Antivertigo medications and drug-induced vertigo. A pharmacological review. Drugs 50: 777-791
15. Stoll W (1996) Sinnvolle Diagnostik und Therapie des Symptoms Schwindel. Dt Ärztebl 93: A-460-464
16. Verspeelt J, De Locht P, Amery WK (1996) Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine. Eur J Clin Pharmacol 51: 15-22
17. Wang JJ, Dutia MB (1995) Effects of histamine and betahistine on rat medial vestibular nucleus neurones: possible mechanism of action of anti-histaminergic drugs in vertigo and motion sickness. Exp Brain Res 105: 18-24